Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This Item 5.07 discloses the results of Hawaiian Electric Industries' Annual Meeting of Shareholders held on June 11, 2026, including detailed voting tallies for the election of all 12 directors, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche as independent auditor. The filing presents complete voting results with share counts for each outcome (For, Against, Abstain, Broker Non-Vote), which is the core purpose of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Bath & Body Works' Annual Meeting of Stockholders held on June 11, 2026. The filing reports voting outcomes on three matters: election of ten directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of executive compensation. The detailed vote tallies and high approval percentages (e.g., 97.35% for executive compensation) are characteristic of routine but material shareholder meeting disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for three proposals: election of 12 directors, advisory approval of named executive officer compensation, and ratification of the independent auditor (Plante & Moran, PLLC). All proposals passed with substantial majorities, and the detailed vote tallies (For/Against/Abstain/Broker Non-Votes) are provided for each director and proposal, which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-15
EX-99.1
This is a news release announcing the voting results from Western Copper and Gold's annual general meeting held on June 12, 2026. The exhibit discloses detailed voting results for the election of seven directors (Raymond Threlkeld, Sandeep Singh, Robert Chausse, Pamela O'Hara, Mark Smith, Michael Vitton, and Klaus Zeitler) and the appointment of PricewaterhouseCoopers LLP as auditor, with specific vote counts and percentages for each. This directly matches the `shareholder_vote_results` event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Encore Capital Group held its Annual Meeting of Stockholders on June 12, 2026, with stockholders voting on six proposals: election of eight directors, a non-binding say-on-pay vote, ratification of BDO USA as independent auditor, approval of an amended 2017 Incentive Award Plan, an amendment to the Certificate of Incorporation for officer exculpation provisions, and the frequency of future say-on-pay votes. All proposals passed with detailed vote tabulations provided.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Precipio's Annual Meeting held on June 15, 2026. The filing reports voting outcomes for two proposals: election of three Class II directors (Richard Sandberg, Christina Valauri, and Jeffrey Cossman, M.D.) and ratification of CBIZ CPAs, P.C. as independent auditor. Both proposals were approved with detailed vote tallies provided. Director elections and auditor ratification are material governance matters affecting reasonable investor assessment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Plug Power held its annual meeting of stockholders on June 11, 2026, with shareholders approving all four proposals: election of four Class III directors (Colin Angle, Jose Luis Crespo, Patrick Joggerst, Gary K. Willis), approval of a 2021 Plan amendment to increase shares reserved by 25 million, an advisory vote on named executive officer compensation, and ratification of Deloitte as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Milestone Pharmaceuticals held its Annual Meeting and disclosed voting results on four proposals: election of eight directors, ratification of PricewaterhouseCoopers LLP as auditor, approval of an amendment to the 2019 Equity Incentive Plan increasing authorized shares by 6.8 million, and an advisory vote on executive compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
uniQure held its Annual Meeting on June 10, 2026, with shareholders voting on 15 proposals including director reappointments, auditor appointment, compensation advisory votes, and amendments to the Articles of Association. The filing discloses detailed voting results (For/Against/Abstain/Broker Non-Votes) for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from Binah Capital Group's Annual Meeting of Stockholders held on June 12, 2026. The filing reports certified voting outcomes for five proposals including director election (Daniel Hynes), executive compensation approval, auditor ratification, and equity plan amendment, with detailed vote counts for each matter. This is material as it documents stockholder decisions on governance and compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Riot Platforms held its 2026 Annual Meeting of Shareholders, with voting results on four proposals: election of directors Lance D'Ambrosio and Michael Turner, ratification of Deloitte & Touche LLP as auditor, advisory approval of named executive officer compensation, and approval of the Seventh Amendment to the 2019 Equity Incentive Plan increasing share reserves by 15 million shares. All proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder voting results from MeiraGTx's June 11, 2026 annual general meeting, including election of three Class II directors (Ellen Hukkelhoven, Nicole Seligman, and Debra Yu) and ratification of Ernst & Young LLP as independent auditor. The filing explicitly states "Based on the above voting results, the director nominees named above were elected and Item 2 was approved," which is the hallmark of Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This Item 5.07 filing discloses the results of Janus International's annual meeting of shareholders held on June 15, 2026, including voting outcomes on three proposals: election of three Class II directors (Paul Vasington, Jeannine Lane, and Eileen M. Youds), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies and confirmation that all proposals passed are the core disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This Item 5.07 disclosure reports the final voting results from the Company's 2026 Annual Shareholders Meeting held on June 12, 2026, including election of seven directors, approval of an amendment to increase authorized shares, and ratification of the independent auditor. All three proposals received requisite approval, making this a standard shareholder vote results disclosure that is material to investors as it confirms governance and capital structure decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Visteon held its annual stockholder meeting on June 11, 2026, with voting results including election of all eight director nominees by substantial majorities, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of executive compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This Item 5.07 disclosure reports the final voting results from Ollie's Bargain Outlet's June 11, 2026 annual meeting of stockholders, including the election of ten directors, advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies for each director and each proposal are the core content of a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
FATE Therapeutics held its Annual Meeting of Stockholders on June 12, 2026, with stockholders approving four proposals: election of three Class I Directors, ratification of Ernst & Young LLP as auditor, non-binding advisory vote on named executive officer compensation, and approval of a third amendment and restatement of the 2022 Stock Option and Incentive Plan increasing available shares by 7,000,000.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of WW International's 2026 annual shareholder meeting held on June 12, 2026. The filing presents voting tallies for three proposals: (1) election of six directors, (2) ratification of PricewaterhouseCoopers LLP as independent auditor, and (3) advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material shareholder vote result disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Stockholders approved five proposals at the Annual Meeting: election of directors Stefan Krause and Lily Mei, ratification of Frank, Rimerman + Co. LLP as independent auditor, advisory approval of named executive officer compensation, annual frequency for say-on-pay votes, and an amendment to the 2021 Equity Incentive Plan increasing authorized shares by 2,860,000 and raising aggregate ISOs to 10,000,000. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder vote results from Lyell Immunopharma's June 10, 2026 annual meeting, covering three proposals: election of Class II directors (Richard Klausner, Otis Brawley, William Rieflin), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents certified voting tallies including votes for/against, withholdings, abstentions, and broker non-votes for each matter, which is the hallmark of Item 5.07 disclosure and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing reports results for two proposals: election of Class II directors (Craig Dixon and Adam Stewart) and ratification of Deloitte & Touche LLP as independent auditor. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder vote results from Pyxis Oncology's Annual Meeting of Stockholders held on June 15, 2026. The filing reports the final voting tallies for two proposals: (1) election of three Class II directors (Thomas Civik, Freda Lewis-Hall, and Michael A. Metzger) and (2) ratification of Ernst & Young LLP as independent auditor. The detailed vote counts (For, Against/Withheld, Abstain, and Broker Non-Votes) are provided for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-15
EX-99.1
The exhibit announces the results of Navigator Gas's 2026 Annual General Meeting of Shareholders held on June 15, 2026. It discloses that shareholders approved two proposals: (1) election of six directors (Dag von Appen, Dr. Heiko Fischer, Janette Marx, Dr. Anita Odedra, Peter Stokes, and Florian Weidinger) to serve until the 2027 Annual General Meeting, and (2) ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026. This is a direct disclosure of shareholder vote results, which is material to investors as it establishes the composition of the board and confirms the auditor for the fiscal year.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder vote results from BJ's Restaurants' Annual Meeting of Shareholders held on June 11, 2026, covering three matters: election of eight directors (all elected with substantial majorities), advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies for each director and each proposal are the hallmark of Item 5.07 disclosure, and the outcomes are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
TerrAscend held its Annual Meeting of Security Holders on June 9, 2026, with shareholders voting on four proposals: election of five directors, ratification of auditor re-appointment, approval of stock option plan, and approval of share unit plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Shareholders approved four proposals at the Annual Meeting: election of four directors (Laura Dempsey Brown, Cariappa Chenanda, Alexander Schuetz, and Ian Walsh), ratification of Grant Thornton LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment and restatement of the 2023 Equity Incentive Plan increasing the share pool by 1,000,000 shares. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder voting results from TechTarget's June 11, 2026 Annual Meeting of Stockholders under Item 5.07. The filing presents detailed vote tallies for three proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and management accountability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of the 2026 annual meeting of stockholders held on June 12, 2026. The filing details three matters voted upon: (1) election of Class III director Michael Kauffman, M.D., Ph.D. (96.04% approval), (2) advisory approval of named executive officer compensation (98.0% approval), and (3) ratification of PricewaterhouseCoopers LLP as independent auditor (99.5% approval). All three are routine shareholder votes with strong approval margins, making this a material disclosure of governance outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-15
The filing discloses Item 5.07 results from Rumble Inc.'s 2026 Annual Meeting of Stockholders held on June 11, 2026. The company reports voting results for two proposals: (1) election of six directors to one-year terms with vote tallies for each nominee (e.g., Chris Pavlovski received 1,153,778,948 votes for), and (2) ratification of Baker Tilly US, LLP as independent auditor with 1,284,679,467 votes for. These are standard shareholder meeting outcomes that are material to investors' understanding of board composition and audit oversight.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-15
The 6-K discloses the results of an Extraordinary General Meeting held on June 12, 2026, where shareholders voted on five material proposals: (1) increase of Class B voting rights from 20 to 100 votes per share, (2) increase of authorized share capital, (3) reduction of par value, (4) adoption of amended charter, and (5) approval of up to five share consolidations at ratios up to 1:1500. All proposals were approved with overwhelming majorities (178.5M+ votes in favor). These charter amendments and voting-rights changes are material governance events affecting the capital structure and shareholder rights.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Protara Therapeutics' Annual Meeting of Stockholders held on June 12, 2026. The filing presents voting results for seven proposals including director elections, auditor ratification, executive compensation approval, equity plan amendment, and charter amendments. Shareholder vote results are material to investors as they reflect stockholder approval of governance and compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-06-15
The filing's primary disclosure is Item 5.07, which reports the results of a special stockholder meeting held on June 12, 2026. The meeting voted on four proposals: (1) approval of a corporate name change from "urban-gro, Inc." to "Flash Sports & Media Holdings, Inc." (787,843 votes for); (2) approval of share issuance upon conversion of Series B Convertible Preferred Stock exceeding 19.99% of outstanding shares (439,372 votes for); (3) approval of share issuance to Hudson Global Ventures and Agile Hudson Partners exceeding 19.99% of outstanding shares (427,276 votes for); and (4) adjournment authority (677,977 votes for). All proposals passed. The name change and dilutive share issuances are material to investors' assessment of the company's capital structure and identity.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-15
EX-99.1
This exhibit is a formal "Report of Voting Results" for Collective Mining's Annual and Special Meeting of Shareholders held on June 15, 2026, disclosing the outcomes of four shareholder votes: election of five directors (all carried with >99% support), appointment of BDO Canada LLP as auditor (carried with 99.998% support), adoption of a new omnibus equity incentive plan (carried with 91.236% support), and approval of unallocated awards under the existing stock option plan (carried with 91.236% support). This is a classic shareholder_vote_results disclosure required under National Instrument 51-102 Section 11.3.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
RenX disclosed final voting results from its Annual Meeting, including director elections, auditor ratification, and critically, shareholder approval of dilutive equity issuances (warrant exercises and convertible note conversions totaling over 205 million shares), directly affecting the company's capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-06-15
The filing discloses the results of a special meeting of stockholders held on June 15, 2026, where the Company convened to vote on proposals outlined in its May 29, 2026 proxy statement. Although the meeting lacked a quorum and was adjourned to June 23, 2026, the disclosure of the stockholder meeting outcome and adjournment falls under Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 8.01 (Other Events), which are the standard vehicles for reporting shareholder vote results and related meeting developments.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
SandRidge Energy held its 2026 Annual Meeting of Stockholders on June 10, 2026, with stockholders voting on four proposals: election of six directors, ratification of Grant Thornton as independent auditor, advisory vote on named executive officer compensation, and approval of the 2016 Omnibus Incentive Plan extension. All four proposals were approved by stockholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
CareDx held its Annual Meeting of Stockholders on June 11, 2026, with voting results disclosed on five proposals including director elections, auditor ratification, executive compensation approval, say-on-pay frequency, and equity plan amendment. All proposals passed with detailed vote tallies reflecting investor approval of the company's governance and capital allocation decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder vote results from JLL Income Property Trust's June 11, 2026 annual meeting. The filing reports voting outcomes on three proposals: election of nine directors (all received majority votes), ratification of KPMG LLP as independent auditor (approved), and three charter amendments (failed to receive required majority of outstanding shares). The detailed vote tallies for each director and proposal are characteristic of Item 5.07 shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder voting results from Trupanion's June 10, 2026 Annual Meeting, including final tallies for three proposals: election of nine directors, ratification of Ernst & Young LLP as auditor, and an advisory say-on-pay vote. The filing presents detailed voting counts (For, Against, Withheld/Abstain, and Broker Non-Votes) for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
InterDigital held its 2026 Annual Meeting of Shareholders and disclosed complete voting results, including director elections, bylaws amendment approval, advisory compensation vote, and auditor ratification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder voting results from AppFolio's 2026 Annual Meeting held on June 12, 2026. The filing reports final vote tallies for three proposals: election of two Class II directors (Olivia Nottebohm and Saori Casey), ratification of PricewaterhouseCoopers LLP as independent auditor, and an advisory vote on named executive officer compensation. This is a quintessential Item 5.07 disclosure with detailed voting results that would materially inform investors about governance outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Filana Therapeutics held its 2026 Annual Meeting of Stockholders on June 11, 2026, with certified voting results on four proposals: election of three directors, amendment to the 2018 Omnibus Incentive Plan, ratification of Ernst & Young LLP as auditor, and an advisory vote on executive compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This Item 5.07 disclosure reports the results of votes at Zevia PBC's 2026 Annual Meeting of Stockholders held on June 10, 2026. The filing presents tabulated voting results for two proposals: (1) election of two Class II directors (Suzanne S. Ginestro and David J. Lee) and (2) ratification of Deloitte & Touche LLP as independent auditor. Both proposals passed with substantial majorities. This is a routine but material shareholder vote result disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure presenting the final voting results from Expro's 2026 annual general meeting held on June 10, 2026. The filing reports results on 11 proposals, including approval of a material cross-border merger transaction (Proposals 1–3), director elections (Proposal 4), executive compensation advisory vote (Proposal 5), and other routine matters. The merger transaction and director elections are material to investors, making this disclosure material overall.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Shareholders held on June 10, 2026. The filing presents voting results for three proposals: election of seven directors, ratification of Tanner LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 45%
filed 2026-06-15
EX-99.1
This exhibit is a notice and proxy statement for an Annual and Extraordinary General Meeting scheduled for July 23, 2026, containing six substantive proposals including auditor reappointment, board reappointment, external director reappointment with RSU grants, non-executive director RSU grants, CEO RSU grant, and approval of a Securities Exchange Agreement with VisionWave Holdings. However, the document is the *notice and solicitation* for the meeting, not the *results* of voting. The meeting has not yet occurred as of the filing date (June 15, 2026). While the VisionWave transaction (Proposal 6) is material M&A activity, this exhibit does not disclose voting results but rather seeks shareholder approval. The most accurate classification is the underlying material event—the VisionWave transaction—which should be classified as `ma_activity`, but the exhibit itself is a governance/voting solicitation document that does not fit cleanly into the taxonomy as presented.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-06-15
The filing's primary disclosure is Item 5.07, which reports the results of Bunker Hill Mining's June 11, 2026 annual meeting of stockholders. The filing details voting outcomes for five proposals: ratification of auditors (MNP LLC), election of six directors, approval of amended RSU and stock option plans, and advisory vote on named executive officer compensation. While Item 5.02 discusses the compensation plan amendments themselves, the central event reported is the shareholder vote results, which is material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-15
The filing discloses results of HCW Biologics Inc.'s 2026 Annual Meeting of Stockholders held on June 15, 2026, with voting outcomes on five proposals: election of Class II directors, ratification of Crowe LLP as auditor, approval of a reverse stock split (1:5 to 1:20 range) to maintain Nasdaq listing, approval of warrant issuance under Nasdaq Rule 5635(d), and approval of warrant repricing. This is a classic Item 5.07 shareholder vote results disclosure, material because the reverse split and warrant approvals directly affect shareholder equity and listing status.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure reporting the certified results of Sprinklr's annual meeting of stockholders held on June 11, 2026. The filing presents voting outcomes for three proposals: (1) election of Stephen M. Ward, Jr. as a Class II director, (2) advisory approval of named executive officer compensation, and (3) ratification of KPMG LLP as independent auditor. All three matters are material governance events that affect investor understanding of board composition, executive compensation oversight, and audit firm selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 75%
filed 2026-06-15
Item 5.07
The controlling stockholder approved via written consent a material private placement involving dilutive issuances exceeding 19.99% of outstanding shares, securities to related parties, and securities to the CEO, materially affecting voting power and ownership structure.
View raw filing on EDGAR →